Oncolytic viruses: finally delivering

British Journal of Cancer
Leonard W Seymour, Kerry Fisher

Abstract

Oncolytic viruses can be found at the confluence of virology, genetic engineering and pharmacology where versatile platforms for molecularly targeted anticancer agents can be designed and optimised. Oncolytic viruses offer several important advantages over traditional approaches, including the following. (1) Amplification of the active agent (infectious virus particles) within the tumour. This avoids unnecessary exposure to normal tissues experienced during delivery of traditional stoichiometric chemotherapy and maximises the therapeutic index. (2) The active cell-killing mechanisms, often independent of programmed death mechanisms, should decrease the emergence of acquired drug resistance. (3) Lytic death of cancer cells provides a pro-inflammatory microenvironment and the potential for induction of an anticancer vaccine response. (4) Tumour-selective expression and secretion of encoded anticancer biologics, providing a new realm of potent and cost-effective-targeted therapeutics.

References

Apr 4, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Mark LyonsKerry D Fisher
Dec 14, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Patrick F KellyDavid A Williams
Feb 15, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Elizabeth Kelly, Stephen J Russell
Jul 17, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ta-Chiang LiuDavid H Kirn
Nov 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Neil N SenzerJohn J Nemunaitis
May 11, 2010·Expert Review of Vaccines·Kevin S CliveGeorge E Peoples
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Feb 9, 2012·Advances in Virology·Maxine Bauzon, Terry W Hermiston
Jul 12, 2012·Nature Biotechnology·Stephen J RussellJohn C Bell
Aug 30, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Lynsey M WhildingIain A McNeish
Mar 8, 2014·Frontiers in Immunology·Maxine Bauzon, Terry Hermiston
Apr 26, 2014·Cancer Immunology Research·E Antonio Chiocca, Samuel D Rabkin
May 2, 2014·Frontiers in Oncology·Zong Sheng GuoDavid L Bartlett
Jun 25, 2014·Molecular Therapy : the Journal of the American Society of Gene Therapy·Elizabeth IlettRichard Vile
Jul 6, 2014·Nature Reviews. Cancer·Brian D LichtyJohn C Bell
Oct 9, 2014·Molecular Therapy : the Journal of the American Society of Gene Therapy·Herbert J ZehDavid L Bartlett
Apr 23, 2015·Current Opinion in Virology·Caroline J BreitbachDavid H Kirn

❮ Previous
Next ❯

Citations

Aug 16, 2016·Clinical Oncology : a Journal of the Royal College of Radiologists·G G Hanna, T Illidge
Jul 28, 2016·Clinical Oncology : a Journal of the Royal College of Radiologists·H S Pandha
Aug 24, 2017·Viruses·Daniel N SantiagoHeiko Enderling
Nov 15, 2017·Nature Communications·Jovan MirceticFrank Buchholz
Sep 6, 2017·Human Gene Therapy·Guy UngerechtsDirk M Nettelbeck
Mar 25, 2019·Expert Opinion on Biological Therapy·Victor Cervera-CarrasconAkseli Hemminki
Mar 29, 2019·Expert Opinion on Biological Therapy·Lino E Torres-Domínguez, Grant McFadden
Jun 22, 2017·EMBO Molecular Medicine·Joshua D FreedmanLeonard W Seymour
Jul 20, 2017·Journal of Leukocyte Biology·Jolien De MunckJoeri L Aerts
Jul 21, 2017·Frontiers in Oncology·Xavier Bofill-De RosCristina Fillat
Jul 20, 2019·BMC Biology·Shivani K ThakerHeather R Christofk
Apr 1, 2020·Frontiers in Oncology·Luca CantiniJoachim G J V Aerts
Aug 7, 2020·Wiley Interdisciplinary Reviews. RNA·Huy-Dung HoangTommy Alain
Jul 28, 2018·Cancers·Curtis W McCloskeyBarbara C Vanderhyden
Jan 11, 2020·Critical Reviews in Biotechnology·Daniel LoewePeter Czermak
Jul 16, 2020·Cancers·Eline JanssenDaniele V F Tauriello
Aug 21, 2020·Applied Microbiology and Biotechnology·Pei-Yang HuXiao-Zhou Mou
Oct 6, 2020·Frontiers in Oncology·Guo-Dong CaoMao-Ming Xiong
Apr 30, 2019·The Journal of Clinical Investigation·Patrick KellishMaria Zajac-Kaye
Aug 10, 2017·Frontiers in Oncology·Sean M O'CathailMaria A Hawkins
Jan 11, 2019·Journal for Immunotherapy of Cancer·Zong Sheng GuoDavid L Bartlett
Mar 19, 2020·Oncolytic Virotherapy·Nadishka JayawardenaMihnea Bostina
Feb 14, 2021·Cancers·Kerry FisherLeonard W Seymour
Dec 9, 2020·Mathematical Biosciences·Pantea PooladvandFederico Frascoli
Aug 17, 2020·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Abdolreza OsaliAbdolreza Esmaeilzadeh
Apr 18, 2021·Journal of Hematology & Oncology·Johannes P W Heidbuechel, Christine E Engeland
Apr 13, 2021·Molecular Therapy : the Journal of the American Society of Gene Therapy·Peter Kok-Ting WanLeonard W Seymour
Dec 19, 2020·Molecular Therapy Oncolytics·Tereza BrachtlovaVictor W van Beusechem
Jul 7, 2021·British Journal of Cancer·Joanna ObaczStefan J Marciniak

❮ Previous
Next ❯

Datasets Mentioned

BETA
GM-CSF

Software Mentioned

EnAd
Vec

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.